S 30 110th Congress Senate Health Administrative procedure Congress Congressional reporting requirements Cytology Department of Health and Human Services Government Operations and Politics Governmental investigations Human embryology Law Medical research Science, Technology, Communications Standards Tissue banks

HOPE Act

Introduced: March 29, 2007 See on congress.gov

Everywhere this bill has been 9 steps

Introduced

In committee

Reported out

Passed House

Passed Senate

To President

Became law

Apr 16, 2007

Referred to the House Committee on Energy and Commerce.

Apr 16, 2007

Received in the House.

Apr 12, 2007

Message on Senate action sent to the House.

Apr 11, 2007

Passed Senate, having acquired the 60 votes required under unanimous consent, without amendment by Yea-Nay Vote. 70 - 28. Record Vote Number: 128. (text as passed Senate: CR S4390-4391)

Apr 11, 2007

Passed/agreed to in Senate: Passed Senate, having acquired the 60 votes required under unanimous consent, without amendment by Yea-Nay Vote. 70 - 28. Record Vote Number: 128.(text as passed Senate: CR S4390-4391)

Apr 11, 2007

Considered by Senate. (consideration: CR S4319-4371, S4386-4391)

Apr 10, 2007

Measure laid before Senate by unanimous consent. (consideration: CR S4237-4294)

Mar 29, 2007

Introduced in the Senate and read twice and ordered held at desk.

Mar 29, 2007

Introduced in Senate

Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

Plain-English summary Congressional Research Service

(This measure has not been amended since it was introduced. The summary has been expanded because action occurred on the measure.)

Hope Offered through Principled and Ethical Stem Cell Research Act or the HOPE Act - (Sec. 3) Amends the Public Health Service Act to require the Secretary of Health and Human Services to develop techniques for the isolation, derivation, production, or testing of stem cells, including pluripotent stem cells that have the flexibility of embryonic stem cells (whether or not they have an embryonic source), that may result in improved understanding of or treatments for diseases and other adverse health conditions, provided that such techniques do not involve: (1) the creation of a human embryo or embryos for research purposes; or (2) the destruction or discarding of, or risk of injury to, a human embryo of embryos other than those that are naturally dead.

Requires the Secretary to: (1) provide guidance concerning the next steps required for additional research; (2) prioritize research with the greatest potential for near-term clinical benefits; (3) take into account techniques outlined by the President's Council on Bioethics and any other appropriate techniques and research; and (4) require assurances from grant applicants, in the case of research involving stem cells from a naturally dead embryo, that no alteration of the timing, methods, or procedures used to create, maintain, or intervene in the development of a human embryo was made solely for the purpose of deriving the stem cells.

Sets forth reporting requirements.

Authorizes appropriations.

(Sec. 4) Directs the Secretary to enter into a contract with the Institute of Medicine to conduct a study to: (1) recommend an optimal structure for an amniotic and placental stem cell bank program; and (2) address pertinent issues to maximize the potential of such technology.

What's happening now April 16, 2007

Referred to the House Committee on Energy and Commerce.

Bill text 3 versions